公开(公告)号：US20210379072A1

公开(公告)日：2021-12-09

申请号：US17287478

申请日：2019-10-21

Applicant: INTRA-CELLULAR THERAPIES, INC.

Inventor： Robert E. DAVIS ,  Kimberly E. VANOVER

IPC: A61K31/519 ,  A61P25/16

Abstract: The disclosure provides methods, treatments and materials for treating diseases or disorders associated with the dopamine D1 receptor intracellular pathway. In particular, the present disclosure provides for methods of treating such diseases and disorders in combination with a dopamine replacement therapy.

公开(公告)号：US20250090536A1

公开(公告)日：2025-03-20

申请号：US18967095

申请日：2024-12-03

Applicant: INTRA-CELLULAR THERAPIES, INC.

Inventor： Robert E. DAVIS ,  Kimberly E. VANOVER

IPC: A61K31/519 ,  A61P25/16

Abstract: The disclosure provides methods, treatments and materials for treating diseases or disorders associated with the dopamine D1 receptor intracellular pathway. In particular, the present disclosure provides for methods of treating such diseases and disorders in combination with a dopamine replacement therapy.